Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Could a 28-Day pill boost brain health in Alzheimer's?
Disease control ENROLLING_BY_INVITATIONThis study tests whether a drug called XBD173 can improve blood flow in the brains of people with mild-to-moderate Alzheimer's disease. About 51 participants will take the drug or a placebo twice daily for 28 days. Researchers will use MRI scans and blood tests to measure changes…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC
-
Heart disease clues: 2000-Person study aims to unlock DCM mysteries
Knowledge-focused OngoingThis study follows 2000 people with dilated cardiomyopathy (a weakened, enlarged heart) over several years. Researchers collect blood for genetic testing and perform heart MRI scans to look for scarring. The goal is to find better ways to diagnose the disease and understand how g…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC